U.S. Senators called drug pricing practices "morally repugnant" and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at the start of a Senate hearing on the rising costs of presc...
Original Article: Senators tell drug company executives pricing is 'morally repugnant'